Regenerative Medicine Experts Assess Pittsburgh’s Medical Research Draw
When asked why research in Pittsburgh, another scientist aptly responded, “[Because] It’s going to happen in Pittsburgh.”
McGowan Institute faculty members recently weighed in on Pittsburgh and its ability to attract large research grants and superb scientific talent. Pittsburgh ranks among the country’s top cities receiving research grants from the National Institutes of Health (NIH). The NIH serves as the world’s largest source of biomedical research aid. Pittsburgh’s large medical hospital systems help make this possible. Their close collaborative relationships with the local universities ensure an environment able to seamlessly move medical research from bench to bedside.
Responding in the recent Pittsburgh Tribune-Review press news were McGowan Institute faculty members:
§ Ronald Herberman, MD, Director of the University of Pittsburgh Cancer Institute, as well as the Associate Vice Chancellor for Cancer Research within the School of Medicine, Department of Health Sciences
§ David Perlmutter, MD, Vira I. Heinz Professor and Chairman of Pediatrics at the University of Pittsburgh, and Physician-in-Chief and Scientific Director of Children's Hospital of Pittsburgh of UPMC Rangos Research Center
§ James Antaki, PhD, Associate Professor within the Department of Surgery at the University of Pittsburgh, with adjunct appointments in the Departments of Mechanical Engineering and Bioengineering, as well as a position at Carnegie Mellon University
§ Christopher Post, MD, PhD, FACS, Medical Staff at St. Francis Medical Center, the Children's Institute, and Allegheny General Hospital in Pittsburgh; Associate Professor at the University of Pittsburgh-School of Medicine; Professor at Drexel University-College of Medicine in Philadelphia; an Adjunct Professor at Carnegie Mellon University; a Lecturer at Chatham College; and President and Scientific Director at Allegheny-Singer Research Institute
The above scientists have research efforts that embrace eradicating cancer through research spanning 19 core facilities, establishing a world-class pediatric academic program within a new 10-story, 230,000-sqft research facility, moving towards clinical testing of an extraordinary heart pump for babies with congenital heart defects, and eliminating painful, common ear infections in babies and toddlers.
These are but a few of the pioneering medical research efforts being conducted in Pittsburgh. When asked why research in Pittsburgh, another scientist aptly responded, “[Because] It’s going to happen in Pittsburgh.”
Illustration: McGowan Institute for Regenerative Medicine.
Read more…
Pittsburgh Tribune-Review (10/22/07)
Pittsburgh Tribune-Review (10/22/07)
Pittsburgh Tribune-Review (10/22/07)
Pittsburgh Tribune-Review (10/21/07)
Responding in the recent Pittsburgh Tribune-Review press news were McGowan Institute faculty members:
§ Ronald Herberman, MD, Director of the University of Pittsburgh Cancer Institute, as well as the Associate Vice Chancellor for Cancer Research within the School of Medicine, Department of Health Sciences
§ David Perlmutter, MD, Vira I. Heinz Professor and Chairman of Pediatrics at the University of Pittsburgh, and Physician-in-Chief and Scientific Director of Children's Hospital of Pittsburgh of UPMC Rangos Research Center
§ James Antaki, PhD, Associate Professor within the Department of Surgery at the University of Pittsburgh, with adjunct appointments in the Departments of Mechanical Engineering and Bioengineering, as well as a position at Carnegie Mellon University
§ Christopher Post, MD, PhD, FACS, Medical Staff at St. Francis Medical Center, the Children's Institute, and Allegheny General Hospital in Pittsburgh; Associate Professor at the University of Pittsburgh-School of Medicine; Professor at Drexel University-College of Medicine in Philadelphia; an Adjunct Professor at Carnegie Mellon University; a Lecturer at Chatham College; and President and Scientific Director at Allegheny-Singer Research Institute
The above scientists have research efforts that embrace eradicating cancer through research spanning 19 core facilities, establishing a world-class pediatric academic program within a new 10-story, 230,000-sqft research facility, moving towards clinical testing of an extraordinary heart pump for babies with congenital heart defects, and eliminating painful, common ear infections in babies and toddlers.
These are but a few of the pioneering medical research efforts being conducted in Pittsburgh. When asked why research in Pittsburgh, another scientist aptly responded, “[Because] It’s going to happen in Pittsburgh.”
Illustration: McGowan Institute for Regenerative Medicine.
Read more…
Pittsburgh Tribune-Review (10/22/07)
Pittsburgh Tribune-Review (10/22/07)
Pittsburgh Tribune-Review (10/22/07)
Pittsburgh Tribune-Review (10/21/07)